VEGF and TNFα signalling disrupt EC barrier function via activation of PI3K/Akt signalling (Di et al., 2009; Cain et al., 2010) and tumour cells transmigrate through EC monolayers via induction of PI3K signalling in ECs (Eum et al., 2004). The gene discussed is AKT1; the disease is neoplasm.